Research map: Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank

Back to the article

Papers in this map

  1. High density lipoprotein as a protective factor against coronary heart disease · Tavia Gordon · 1977 · 5069 citations · Cited by this paper
  2. The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention · 2026 · Related
  3. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE · George J. Miller · 1975 · 2627 citations · Cited by this paper
  4. Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study · 2026 · Related
  5. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel · Jan Borén · 2020 · 1609 citations · Cited by this paper
  6. Beyond Survival: The Eriksen Case and the Dilemma of Elite Sport Participation After Sudden Cardiac Arrest · 2026 · Related
  7. HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events · Anand K. Rohatgi · 2014 · 1417 citations · Cited by this paper
  8. Cardiovascular prevention in childhood and young adults · 2026 · Related
  9. THE TROMSØHEART-STUDY · N.E. Miller · 1977 · 1205 citations · Cited by this paper
  10. Rethinking how we characterize the exercise blood pressure response in athletes · 2026 · Related
  11. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies · Christian Medom Madsen · 2017 · 724 citations · Cited by this paper
  12. Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease · 2026 · Related
  13. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias · François Mach · 2025 · 601 citations · Cited by this paper
  14. Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention · 2026 · Related
  15. High-density lipoprotein revisited: biological functions and clinical relevance · Arnold von Eckardstein · 2022 · 397 citations · Cited by this paper
  16. Safe hearts need a healthy environment: prevention beyond our clinic walls · 2026 · Related
  17. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk · Brian A. Ference · 2017 · 330 citations · Cited by this paper
  18. Multidisciplinary cardiac rehabilitation—an indispensable therapeutic intervention when starting a GLP-1 receptor agonist therapy? · 2026 · Related
  19. Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes · Jon White · 2016 · 320 citations · Cited by this paper
  20. Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history · 2026 · Related
  21. Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy · Annapoorna Subhash Kini · 2013 · 283 citations · Cited by this paper
  22. Novel Biological Functions of High-Density Lipoprotein Cholesterol · Chieko Mineo · 2012 · 228 citations · Cited by this paper
  23. Coronary Atherosclerotic Plaque Regression · Luke P. Dawson · 2022 · 195 citations · Cited by this paper
  24. Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study · Elias Björnson · 2023 · 181 citations · Cited by this paper
  25. Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk · Tamara Glavinovic · 2022 · 165 citations · Cited by this paper
  26. Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events · Jane Armitage · 2019 · 147 citations · Cited by this paper
  27. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy · MacRae F. Linton · 2023 · 142 citations · Cited by this paper
  28. Discordance among apoB, non–high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention · Allan D. Sniderman · 2024 · 115 citations · Cited by this paper
  29. simPH : An R Package for Illustrating Estimates from Cox Proportional Hazard Models Including for Interactive and Nonlinear Effects · Christopher Gandrud · 2015 · 80 citations · Cited by this paper
  30. Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol · Elias Björnson · 2024 · 64 citations · Cited by this paper
  31. A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery disease · Qingyuan Zhao · 2021 · 53 citations · Cited by this paper
  32. High-density lipoprotein characteristics and coronary artery disease: a Mendelian randomization study · Albert Prats‐Uribe · 2020 · 46 citations · Cited by this paper
  33. The role of high‐density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity · Marisa Fernandes das Neves · 2021 · 40 citations · Cited by this paper
  34. ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease · Jakub Morze · 2025 · 37 citations · Cited by this paper
  35. Transcytosis of LDL Across Arterial Endothelium: Mechanisms and Therapeutic Targets · Israel Olapeju Bolanle · 2025 · 26 citations · Cited by this paper
  36. The Causal-Benefit Model to Prevent Cardiovascular Events · Ciaran Navin Kohli-Lynch · 2024 · 20 citations · Cited by this paper
  37. Cell-free, high-density lipoprotein–specific phospholipid efflux assay predicts incident cardiovascular disease · Masaki Satō · 2023 · 18 citations · Cited by this paper
  38. Discordance Analysis of VLDL-C and ApoB in UK Biobank and Framingham Study: A Prospective Observational Study · S. Bilgiç · 2024 · 14 citations · Cited by this paper
  39. Distinct roles of size-defined HDL subpopulations in cardiovascular disease · William Sean Davidson · 2024 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)